206 patients ( mean age 56.7 years , 61 % male ) undergoing outpatient screening or surveillance colonoscopies were prospectively randomized to receive either 4-L SF-PEG ( n = 104 ) or 2-L PEG + Asc solution ( n = 102 ) .